CTOs on the Move

digiChart

www.digichart.com

 
digiChart Announces New Executives and New Offices July 15, 2010 BRENTWOOD, Tenn.--(BUSINESS WIRE)--digiChart, Inc. today announced the appointment of two new members to its executive team, Bob Allen and Stephen Faris. The company also announced the relocation of its headquarters to Brentwood, TN, a nearby suburb of Nashville, TN. Bob Allen joins digiChart as National Director of Sales. Mr. Allen will be responsible for all the sales and marketing efforts of the company. Most recently, he served as Vice President of Sales in McKessons Physician Practice Solutions business. He brings over 20 years experience in sales and healthcare technology. Stephen ...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.digichart.com
  • 100 Winner's Circle, Suite 450
    Brentwood, TX USA 37027
  • Phone: 615.777.2727

Executives

Name Title Contact Details
Stephen Faris
Chief Technology Officer Profile
Stephen Faris
Vice President of Technology Profile

Similar Companies

Global Healthcare Public Foundation Inc

Global Healthcare Public Foundation Inc is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cosmetic LaserWorks

Cosmetic LaserWorks is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InterPro Health

InterPro is a leading global provider of business process outsourcing services. We deliver transcription services, contact center solutions, document management, enterprise portal development, employer services, medical revenue lifecycle support, and

Five Prime Therapeutics

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company’s product candidates include FP-1039/GSK3052230, a protein therapeutic is in PhaseIb clinical trials for trapping and neutralizing cancer-promoting fibroblast growth factors (FGFs) involved in cancer cell proliferation and new blood vessel formation; FPA008, an antibody that inhibits colony stimulating factor-1 receptor; and FPA144 is an antibody for inhibiting FGF receptor 2b, as well as to treat patients with gastric cancer and potentially other solid tumors. It has collaboration and license agreements with GlaxoSmithKline LLC, Glaxo Group Limited, GSK-HGS, Pfizer Inc., and UCB Pharma S.A. The company was founded in 2001 and is headquartered in South San Francisco, California.

MedSource Consulting

MedSource Consulting is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.